BRANDY NORRIS: Open Payments
NPI 1053151001 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 23 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $259 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $268 |
| Janssen Pharmaceuticals, Inc | 1 | $124 |
| ABBVIE INC. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $20 |
Products named: INGREZZA, INVEGA SUSTENNA, VRAYLAR, COBENFY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
